We are live on ! Find out more
MGP

M&G plc Portfolio holdings

AUM $20.1B
1-Year Est. Return 16.62%
This Fund
S&P 500
This Quarter Est. Return
-0.47%
1 Year Est. Return
+16.62%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$19.4B
AUM Growth
-$107M
Cap. Flow
-$6.32M
Cap. Flow %
-0.03%
Top 10 Hldgs %
31.82%
Holding
423
New
51
Increased
131
Reduced
125
Closed
43
Avg Time Held Equity + Options
5.2 quarters
Top 10 Avg Time Held Equity + Options
4.3 quarters
Top 20 Avg Time Held Equity + Options
4.1 quarters
Avg Time Held Equity only
5.3 quarters
Top 10 Avg Time Held Equity only
4.3 quarters
Top 20 Avg Time Held Equity only
4.1 quarters

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$811M
2
MSFT icon
Microsoft
MSFT
+$183M
3
INTU icon
Intuit
INTU
+$152M
4
AVGO icon
Broadcom
AVGO
+$130M
5
MICC icon
The Magnum Ice Cream Company N.V.
MICC
+$102M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$190M
2
ELV icon
Elevance Health
ELV
+$109M
3
CME icon
CME Group
CME
+$92.3M
4
BMY icon
Bristol-Myers Squibb
BMY
+$79.9M
5
HTHT icon
Huazhu Hotels Group
HTHT
+$67.8M

Sector Composition

Rank Sector Weight
1 Technology 20.64%
2 Healthcare 16.38%
3 Consumer Discretionary 15.42%
4 Financials 11.36%
5 Communication Services 6.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
MSFT icon
1
Microsoft
MSFT
$3.97T
$1.06B 5.47%
2,861,372
+437,829
+18% +$183M
2024 Q1
8 quarters
AMCR icon
2
Amcor
AMCR
$19.3B
$1.01B 5.2%
25,183,844
+2,185,925
+10% +$96.7M
2024 Q1
8 quarters
AZN icon
3
AstraZeneca
AZN
$247B
$817M 4.22%
+4,204,199
New +$811M
2026 Q1
0 quarters
MEOH icon
4
Methanex
MEOH
$4.8B
$747M 3.86%
12,453,376
-303,555
-2% -$15.3M
2024 Q1
8 quarters
META icon
5
Meta Platforms (Facebook)
META
$1.83T
$533M 2.75%
930,993
+53,855
+6% +$34.5M
2024 Q1
8 quarters
GOOGL icon
6
Alphabet (Google) Class A
GOOGL
$4.3T
$465M 2.4%
1,615,529
+94,448
+6% +$29.7M
2024 Q1
8 quarters
VFC icon
7
VF Corp
VFC
$5.9B
$438M 2.26%
25,786,464
+235,763
+0.9% +$4.45M
2024 Q1
8 quarters
NEE icon
8
NextEra Energy
NEE
$161B
$375M 1.94%
4,034,446
-744,401
-16% -$66.2M
2024 Q1
8 quarters
AVGO icon
9
Broadcom
AVGO
$1.73T
$368M 1.9%
1,187,993
+395,812
+50% +$130M
2024 Q1
8 quarters
BMY icon
10
Bristol-Myers Squibb
BMY
$121B
$352M 1.82%
5,764,140
-1,371,341
-19% -$79.9M
2024 Q1
8 quarters
WFC icon
11
Wells Fargo
WFC
$253B
$313M 1.61%
3,906,676
+441,799
+13% +$37.9M
2024 Q1
8 quarters
MDT icon
12
Medtronic
MDT
$113B
$292M 1.51%
3,359,670
+825,879
+33% +$79.1M
2024 Q1
8 quarters
TTE icon
13
TotalEnergies
TTE
$190B
$292M 1.51%
3,118,948
-190,520
-6% -$14.6M
2025 Q4
1 quarter
AAPL icon
14
Apple
AAPL
$4.91T
$278M 1.44%
1,094,595
+49,613
+5% +$12.9M
2024 Q1
8 quarters
EQIX icon
15
Equinix
EQIX
$101B
$277M 1.43%
282,809
-29,681
-9% -$26.4M
2024 Q1
8 quarters
V icon
16
Visa
V
$724B
$264M 1.36%
873,350
+139,379
+19% +$44.8M
2024 Q1
8 quarters
JCI icon
17
Johnson Controls International
JCI
$95.4B
$262M 1.35%
2,000,914
-382,554
-16% -$49.4M
2024 Q1
8 quarters
NVDA icon
18
NVIDIA
NVDA
$5.54T
$254M 1.31%
1,460,195
+45,890
+3% +$8.42M
2024 Q1
8 quarters
RSG icon
19
Republic Services
RSG
$66.4B
$250M 1.29%
1,143,610
-40,868
-3% -$8.97M
2024 Q1
8 quarters
HTHT icon
20
Huazhu Hotels Group
HTHT
$13.9B
$234M 1.21%
4,677,290
-1,329,651
-22% -$67.8M
2024 Q1
8 quarters
UNH icon
21
UnitedHealth
UNH
$340B
$230M 1.19%
847,584
-19,171
-2% -$5.71M
2024 Q1
8 quarters
FNV icon
22
Franco-Nevada
FNV
$47.2B
$220M 1.14%
889,974
-135,781
-13% -$33.6M
2024 Q1
8 quarters
QCOM icon
23
Qualcomm
QCOM
$187B
$216M 1.12%
1,674,676
-143,113
-8% -$20.9M
2024 Q1
8 quarters
ACN icon
24
Accenture
ACN
$128B
$214M 1.1%
1,078,492
+41,503
+4% +$9.67M
2024 Q1
8 quarters
MICC icon
25
The Magnum Ice Cream Company N.V.
MICC
$10.4B
$213M 1.1%
14,172,252
+6,293,273
+80% +$102M
2025 Q4
1 quarter
1
2 3 4 5

Similar funds

JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
CWP
Capital Wealth Planning Naples, Florida $20B AUM 25.34% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $19.9B AUM 44.71% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

M&G plc's Q1 2026 Portfolio in Review

As of Q1 2026, M&G plc held 423 positions worth $19.4B, down 0.55% from $19.5B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

M&G plc's Q1 2026 filing shows 51 new, 131 increased, 125 reduced and 43 closed positions. Its largest new stake was AstraZeneca: 4,204,199 shares worth $817M. The largest sale was Lam Research, an estimated $190M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • M&G plc's largest Q1 2026 buy was AstraZeneca: 4,204,199 shares worth $817M.
  • M&G plc added most to Microsoft in Q1 2026, an estimated $183M increase.
  • M&G plc's biggest Q1 2026 reduction was Lam Research, cutting an estimated $190M.
  • M&G plc fully exited Crown Castle in Q1 2026, selling an estimated $34M.
  • M&G plc's ten largest holdings make up 32% of its $19.4B portfolio in Q1 2026.
  • M&G plc opened 51 new positions and closed 43 in Q1 2026.
  • M&G plc's portfolio value fell 0.55% quarter-over-quarter to $19.4B.

Based on M&G plc's 13F filing for Q1 2026, filed 13 May 2026.